Setting Genotoxic Impurities Limits in Drug Substance: A Practical Guide,

Introduction

Genotoxic impurities (GTIs) are chemical substances that can damage DNA, potentially causing mutations and cancer. Even at very low levels, GTIs pose a safety risk, so they are strictly controlled in pharmaceuticals.

Unlike normal impurities (which are usually controlled as a percentage of the drug substance, e.g., 0.10% or 0.15%), GTIs are controlled in ppm (µg/g) or µg/day exposure, because even trace levels of these impurities can be harmful.

This article explains:

1. How to decide whether an impurity is genotoxic.

2. The TTC principle used for setting limits.

 3. A simple formula to calculate genotoxic impurity limits with examples.

Step 1: How to Determine Whether an Impurity is Genotoxic

Before setting a limit, we must identify whether the impurity has DNA-reactive potential or not . The common approach is:

1. Structural Alert Screening:

Check the impurity’s chemical structure for functional groups known to be genotoxic (e.g., nitrosamines, alkyl halides, epoxides, aziridines, hydrazines).

Use in-silico tools like QSAR (Quantitative Structure–Activity Relationship) to predict genotoxicity.

2. In-Vitro Testing

If QSAR gives a structural alert → perform a bacterial reverse mutation test (Ames test).

Positive Ames test = impurity considered genotoxic → must apply TTC principle.

3. If No Structural Alert

If no alert in QSAR and negative Ames test → impurity is non-genotoxic → then it can be controlled like ordinary impurities (per ICH Q3A/Q3B).

Summary Rule:

Alert/Positive result → Genotoxic impurity (control at ppm).

No alert/Negative → Non-genotoxic impurity (control as normal).

Regulatory classification:

EMA guideline “Guideline on the Limits of Genotoxic Impurities” classifies impurities into categori tv aa,es:

Class 1: Known potent carcinogens (e.g., nitrosamines).

Class 2: Probable genotoxic carcinogens.

Class 3: Alerting structure, unknown carcinogenicity.

Class 4/5: No concern.

👉 If classified as genotoxic (Class 1–3) → apply TTC/AI limit.

Step 2: TTC Principle (Threshold of Toxicological Concern)

Default limit for GTIs: 1.5 µg/day exposure

This corresponds to a lifetime cancer risk of 1person in 100,000.

If carcinogenic potency data exists (like nitrosamines), a compound-specific AI (Acceptable Intake) may be lower than 1.5 µg/day.

Step 3: Simple Formula for Genotoxic Impurity Limit

To set genotoxic impurity limit like other impurities limit you need to know the maximum daily dose of the drug, If you know the maximum daily dose in mg convert it the gram

If the maximum daily dose (MDD) of the drug is expressed in grams, dived the TTC limit in (µg/day) with the MDD in gram.

And the formula becomes very simple as below:

GTIs Limit (ppm)

=TTC (µg/day)/Daily Dose (g/day)

Step 4: Examples

Example 1: Olaparib (Maximum daily dose is 600 mg/day = 0.6 g/day)

Limit=1.5/0.6=2.5 ppm 

Example 2: Paracetamol (4000 mg/day = 4 g/day)

Limit=1.5/4=0.375 ppm

 

Observation:

Higher daily dose → Stricter (lower) ppm limit.

Lower daily dose → Relaxed (higher) ppm limit.

By this way we can set the limit for genotoxic impurities but for Nitrosamine approach is little bit different as these impurities need more stringent control.

Special Case – Nitrosamines

Nitrosamines are extremely potent as they are known carcinogens, so they do not use the TTC of 1.5 µg/day. Instead, they have individual Average daily intake (AI) values:

To set limit for these impurities First convert Their AI value from ng/day to µg/day by just dividing ng/day value with 1000, like for NDMA AI value is 96 ng/day. After dividing with 1000 it will become 0.096 µg/day.

NDMA = 96 ng/day

NDEA = 26.5 ng/day

DIPNA = 26.5 ng/day, etc.

Example1: NDMA in a 1 g/day drug

Limit=0.096/1=0.096ppm

(much stricter than 1.5 µg/day TTC).

Example 2: NDMA in a 0.5 g/day Drug (500 mg/day)

Limit=0.096/0.5=0.192ppm

Example 3: NDEA in a 2 g/day Drug

Limit=0.0265/2=0.013

Normally, genotoxic impurity limits are based on lifetime exposure (around 70 years). 

But if the drug is only taken for a shorter duration (e.g., 24 months for oncology therapy), regulators allow higher daily exposure because the total cumulative risk is lower.

Step 1: The principle

Default TTC (lifetime use) = 1.5 µg/day (≈ 70 years).

For shorter duration use, TTC is adjusted upward using scaling factors.

EMA/ICH guidance gives the following approximate acceptable intakes (AI):

Treatment Duration                AI (µg/day)

Lifetime (≥10 years).                  1.5 µg/day

1–10 years                                    10 µg/day

1–12 months                                60 µg/day

≤1 month                                     120 µg/day

Step 2: For 24 months (2 years) exposure

This falls in the 1–10 years category.

👉 Acceptable Intake (AI) = 10 µg/day instead of 1.5 µg/day.

Step 3: Formula for ppm limit

Limit (ppm)=AI (µg/day)/Daily Dose (g/day)

Step 4: Example Calculations:

Example 1: Drug dose = 1 g/day, exposure = 24 months

Limit=10/1=10ppm

Example 2: Drug dose = 0.5 g/day, exposure = 24 months

Limit=10/0.5=20ppm

Conclusion

Step 1: Determine genotoxicity (QSAR + Ames test).

Step 2: If genotoxic, apply TTC (1.5 µg/day) unless a compound-specific AI is available.

Step 3: Use the simplified formula:

Limit (ppm)=

TTC or AI (µg/day)/Daily Dose (g/day)

Step 4: For nitrosamines, use their very low AI values instead of TTC.

This approach ensures both patient safety and regulatory compliance when setting genotoxic impurity limits.

 

 

Understanding Genotoxic, Nitrosamine, Carcinogenic, and Mutagenic Impurities in Pharmaceuticals

In the pharmaceutical industry, patient

Photostability testing: A comprehensive guide

In the pharmaceutical world, the term photostability is frequently encountered—and for good reason. It plays a crucial role in ensuring the safety, efficacy, and quality of drug products. Recognizing its importance, the International Council for Harmonisation (ICH) has dedicated a specific guideline to this topic: ICH Q1B . This guideline outlines the requirements for photostability testing of new drug substances and products. 

But what exactly is photostability, and why does it deserve such focused attention? In this article, we’ll delve deep into the concept of photostability, exploring its significance, testing approaches, regulatory expectations, and how it impacts the overall development and lifecycle of pharmaceutical products. Let’s begin our exploration into the world of photostability.

What is Photostability?

Photostability refers to the stability of a pharmaceutical substance or product when exposed to light. It is an essential part of stability testing to determine how light exposure affects the quality, potency, and safety of a drug.

Photostability testing is required as per ICH Q1B guidelines, ensuring that pharmaceutical products remain effective throughout their shelf life and do not degrade into harmful byproducts when exposed to light.

Why Perform Photostability Testing?

Regulatory Requirement – Compliance with ICH Q1B and national regulatory guidelines (e.g., FDA, EMA).

Quality Assurance – Ensures that the drug maintains its efficacy, potency, and safety over time.

Formulation Development – Helps in selecting appropriate packaging and storage conditions.

Degradation Profiling- Identifies degradation products formed due to light exposure.

Labeling Requirements – Determines if the product requires protection from light.

How to Perform Photostability Testing?

1. Selection of Samples:

Drug Substance (API) – Pure active pharmaceutical ingredient.

Drug Product – Finished dosage form (tablet, capsule, solution, etc.).

Placebo – Without API (to check if excipients degrade).

Marketed Package – If applicable, to evaluate light protection.

2. Light Sources Used

As per ICH Q1B guidelines, samples must be exposed to:

Fluorescent Light (cool white light): Mimics indoor storage conditions.

Near UV Light (320–400 nm): Mimics sunlight exposure.

Intensity Requirement:

1.2 million lux hours (visible light)

200 watt-hours/m² (UV light).

3. Exposure Conditions:

Place the samples in a photostability chamber under controlled temperature and humidity.

Expose the samples to light for a specified duration to meet ICH requirements.

If degradation occurs quickly, an accelerated study can be done.

4. Post-Exposure Testing:

After light exposure, test samples for:

Appearance changes (color change, precipitation, melting).

Assay of API using HPLC or UV Spectroscopy.

Degradation product profiling using HPLC, LC-MS, or GC-MS.

Calculations in Photostability Testing

1. Light Exposure Calculation

The required light exposure is:

Visible light (lux hours)

Exposure= lluminance (lux)×Time (hours)

Example: If a sample is placed in 6000 lux for 200 hours:

6000×200=1.2million lux hours

UV Light (watt-hours/m²)

Exposure=UV Intensity (W/m²)×Time (hours)

Example: If a UV source provides 2 W/m² and the exposure lasts 100 hours:

2×100=200watt-hours/m²

2. Degradation Calculation

Percentage Degradation

%Degradation=(Initial Assay−Final Assay)/

                                       Initial Assay)×100

Example:

Initial Assay: 100%.

Final Assay after exposure: 95%

=(100−95)/100×100=5% degradation

If degradation is more than 5%, formulation or packaging changes may be required.

What is rationale Behind 1.2 Million Lux-Hours and 200 W·h/m² in Photostability Testing (ICH Q1B).

The limits set in ICH Q1B guidelines—1.2 million lux-hours (visible light) and 200 W·h/m² (UV light)—are designed to simulate real-world light exposure over a product's shelf life. These values were derived based on worst-case scenarios for typical pharmaceutical storage and handling conditions.

Definition:

Lux is a measure of illuminance (light intensity per unit area).

Lux-hours is a cumulative measure of light exposure over time.

Rationale:

The 1.2 million lux-hours simulates the amount of light a pharmaceutical product may experience during normal storage, transportation, and use over its shelf life.

Many pharmaceuticals are stored in warehouses, pharmacies, and hospitals where fluorescent or ambient light exposure is common.

This limit ensures that products remain stable under practical light conditions without excessive degradation.

Example Calculation:

If a product is exposed to 6000 lux of light in a pharmacy for 200 hours:

6000×200=1.2million lux-hours

This simulates real-world exposure over several months to years in well-lit conditions.

2. Why 200 W·h/m² for UV Light?

Definition:

Watts per square meter (W/m²) measures UV light intensity.

Watt-hours per square meter (W·h/m²) measures total UV energy received over time.

Rationale:

UV light (320–400 nm) can cause photodegradation of pharmaceuticals by breaking chemical bonds.

200 W·h/m² represents the cumulative UV exposure from sunlight and artificial sources during product distribution and storage.

This value simulates exposure a product might receive if stored near windows, under artificial UV light, or exposed to sunlight during transportation.

Example Calculation:

If a UV source provides 2 W/m², the exposure time needed to reach 200 W·h/m² would be:

200/2=100 hours.

3.What is normal average white light intensity in the room?

The normal average white light intensity in a room depends on the type of lighting and its purpose. Here are typical values:

Indoor Light Intensity Levels (in Lux)

Home (Living Room, Bedroom): 100–300 lux

Office, Classroom: 300–500 lux

Supermarket, Retail Stores: 500–1000 lux

Hospital, Laboratories: 1000–2000 lux

Surgical Room, Inspection Areas: 2000–10000 lux.

Comparison with ICH Q1B Requirement

Typical room lighting (300–500 lux) would take 2400 to 4000 hours (~3–6 months) to reach 1.2 million lux-hours.

This confirms that ICH Q1B testing simulates long-term real-world light exposure in a much shorter time (e.g., a few days in a high-intensity photostability chamber).

4. How to calculate Time Required to Reach 1.2 Million Lux-Hours in a Normal Room

Formula

Lux-Hours=Illuminance (lux)×Time (hours)

To determine how long it takes for a product in a typical room to reach 1.2 million lux-hours, we solve for time:

Time (hours)=1,200,000 lux-hours/

Room Light Intensity (lux)

Example: Suppose we have kept about 2 g sample in a petridish for 15 hours in photo stability chamber which visible light intensity is about 5000 lux and uv light intensity is 3.1 Watt/m2

So calculate the total exposLet's calculate both visible light exposure (lux-hours) and UV exposure (W·h/m²) based on the given conditions.

Let's calculate both visible light exposure (lux-hours) and UV exposure (W·h/m²) based on the given conditions.

Given Data:

• Sample weight: 2 g (not needed for light exposure calculation)

• Exposure time: 15 hours

• Visible light intensity: 5000 lux

• UV light intensity: 3.1 W.h/m²

Visible Light Exposure (Lux-Hours Calculation)

Lux-Hours=Illuminance (lux)×Time (hours)

Lux-Hours=5000×15=75,000 lux-hours

UV Light Exposure (Watt-Hours per Square Meter Calculation)

UV Exposure (W/m²)=

UV Intensity (W.h/m²)×Time (hours)

  =3.1×15=46.5W/m²

Final Answer:

Total Visible Light Exposure = 75,000 lux-hours

Total UV Exposure = 46.5 W·h/m2

Comparison with ICH Q1B Requirements:

Required visible light exposure = 1.2 million lux-hours

Our exposure (75,000 lux-hours) is only 6.25% of the required amount.

Required UV exposure = 200 W·h/m²

Your exposure (46.5 W·h/m²) is 23.25% of the required amount.

Conclusion: Our current exposure is much lower than ICH Q1B requirements. To meet full ICH Q1B criteria, We would need to extend the exposure time.

 But how much time we need to meet the requirements 

We can calculate with below formula that we discussed before.

Required Time for Visible Light Exposure

Using the formula:

Time=ICH Required Luxurious / Lux Intensity

Time=1,200,000/5000  =240hours

So, we need to expose the sample for 240 hours or if calculate in day terms it would be 10 days to meet the visible light requirement

Required Time for UV Exposure:

Using the formula:

Time=ICH Required UV Exposure (W/hm²)/

UV Intensity (W/m²)

 

Time=200÷3.1=64.5 hours

So, We need to expose the sample for 64.5 hours or almost 2.6 days.

 

Types of Degradation and Chemical Reactions in Photostability Testing

1)Photodecomposition (Direct Absorption)

The drug absorbs light and breaks chemical bonds, leading to decomposition.

Eg. Riboflavin, Amphotericin B

2) Photooxidation

Light energy transfers to oxygen, generating reactive oxygen species (ROS) that oxidize the drug.

Eg. Ascorbic acid, Adrenaline, Simvastatin

3) Photoreduction

Light-induced reduction reactions alter the oxidation state of the drug.

4) Photocyclization

Light induces a rearrangement or ring formation in the chemical structure

Eg. Tetracyclines, Ciprofloxacin

5) Photoisomerization.

The drug undergoes isomerization (cis–trans conversion) due to light absorption.

Eg. Retinoids, Diclofenac, Omeprazole

6) Photohydrolysis

Light exposure causes hydrolysis in the presence of water.

Some Example Drugs and Degradation Products:

Nifedipine → Converts to an inactive nitroso derivative.

Furosemide → Forms colored impurities, reducing potency.

Amiodarone → Forms toxic iodine-containing degradation products.

Tetracyclines → Undergo photoisomerization, forming epitetracyclines, which are toxic.

Chlorpromazine → Forms sulfoxide, reducing potency.

Vitamin B2 (Riboflavin) → Undergoes photooxidation, leading to inactive compounds.

Ibuprofen → Forms hydroperoxides, affecting stability.

Buffer selection and it's important in HPLC method development

 

During HPLC method development, buffer selection plays a critical role, especially when working with ionizable compounds. As analytical scientists, understanding the principles behind buffer selection and pH control is essential for optimizing chromatography performance. In this article, we will explore key concepts such as buffer selection, buffer capacity, and the relationship between buffer pKa and pH by answering important questions related to the topic.

1. What is a Buffer?

A buffer solution is made up of a weak acid and its conjugate base, or a weak base and its conjugate acid. Its primary function is to resist changes in pH. In the context of HPLC, buffers stabilize the pH of the mobile phase, which is crucial for achieving consistent chromatographic results, especially with ionizable compounds.

Components of a Buffer Solution:

Acidic Buffer: Weak acid and its conjugate base (e.g., Acetic acid and Sodium acetate).

Basic Buffer: Weak base and its conjugate acid (e.g., Ammonia and Ammonium chloride).

How Buffers Work:

When an acid is added, the buffer’s conjugate base neutralizes the hydrogen ions (H⁺), preventing a significant pH change. Example:

CH₃COO⁻ + H⁺ ⇌ CH₃COOH

When a base is added, the weak acid neutralizes hydroxide ions (OH⁻), maintaining a stable pH. Example:

CH₃COOH + OH⁻ ⇌ CH₃COO⁻ + H₂O

2. Why and When are Buffers Required in HPLC?

Buffers are essential when working with ionizable compounds (weak acids or bases), particularly in reversed-phase HPLC (RP-HPLC). Non-ionizable compounds like caffeine do not require buffers as they remain unaffected by pH changes.

For ionizable compounds, pH changes affect their retention behavior because they exist in both ionized and non-ionized forms depending on the pH. The addition of buffers in the mobile phase helps stabilize the pH, ensuring consistent ionization states of analytes. This leads to:

-Consistent retention times

-Improved peak shapes

-Enhanced resolution

3. How to Identify Ionizable Compounds? 

Look for specific functional groups in the chemical structure:

Acidic Groups: Carboxyl (-COOH), Sulfonic Acid, or Phosphoric acid groups, which ionize at higher pH, resulting in a negative charge.

Basic Groups: Amine (-NH₂) or Imidazole groups, which ionize at neutral to low pH.

Amphoteric Molecules: Compounds like amino acids, which have both acidic and basic groups, can ionize at both low and high pH.

Example:

Ibuprofen: Contains a carboxyl group (-COOH), which ionizes at pH > 4.9.

Lidocaine: Contains an amine group (-NH₂), which becomes protonated in acidic conditions (pH < 7.9).

4. How to perform buffer Selection Based on pKa and Mobile Phase pH?

To select an appropriate buffer, you must understand the pKa of the analyte. The ideal mobile phase pH is typically within ±2 units of the analyte's pKa. This is crucial for controlling the ionization state of the analyte and optimizing retention in chromatography.

Key Concept: The Henderson-Hasselbalch equation helps explain this relationship:

If the pH = pKa, the analyte is 50% ionized and 50% non-ionized, which can cause inconsistent chromatography.

For acidic analytes, a pH lower than the pKa by 2 units ensures the compound is 99% non-ionized, favoring stronger retention in reverse-phase columns like C18.

pH and Retention Examples in RP-HPLC:

Weak acid with a pKa of 4.0:

At pH 2.0 (below pKa), the compound is mostly non-ionized, leading to stronger retention.

At pH 6.0 (above pKa), the compound is mostly ionized, resulting in shorter retention.

5. How to Choose the Right Buffer ?

The buffer's pKa should be close to the desired pH of the mobile phase since buffers work effectively within ±1 pH unit of their pKa.

Example:

If the mobile phase requires a pH of 7.0, KH₂PO₄ buffer (pKa values: 2.1, 7.2, 12.3) is suitable as it can buffer between 6.2 to 8.2.

For a pH of 4.0, acetate buffer is a better choice (pKa ~4.8) than KH₂PO₄.

6. What is buffer capacity and it's important in method development?

Buffer capacity refers to the ability of a buffer solution to resist changes in pH when small amounts of an acid or base are added. It helps in following ways:

-Maintaining pH stability

-Controlling ionization of analytes

-Preventing column degradation

-Reproducibility 

Practical guidelines for buffer capacity in HPLC:

A) Buffer concentration: A typical concentration range is between 10 mM to 50 mM. Higher concentrations provide greater buffer capacity but may cause issues such as higher viscosity, increased back pressure, or interference with the detector (especially in UV detection).

B) Buffer pKa: The buffer should have a pKa close to the pH of the mobile phase, ideally within ±1 pH unit. This ensures optimal buffering capacity because a buffer is most effective at its pKa value.

C) Application-specific adjustments: The required buffer capacity can vary depending on factors like the pH stability of the analytes, column type, and detection method. In some cases, lower buffer concentrations may be sufficient if the system or analytes are not highly sensitive to pH changes.

A good rule of thumb is to choose a buffer concentration that maintains stable pH while not interfering with chromatographic performance or detection.

7) Why are phosphate buffers commonly used?

Phosphate buffer is a commonly used buffer solution in biochemistry and molecular biology.

The pKa values of phosphate buffer depend on the specific phosphate species present. Phosphate has multiple pKa values due to its ability to donate or accept protons (H+ ions).

Here are the pKa values for the phosphate buffer:

1. pKa1 = 2.14 (H3PO4 → H2PO4- + H+)

2. pKa2 = 7.20 (H2PO4- → HPO42- + H+)

3. pKa3 = 12.32 (HPO42- → PO43- + H+)

These pKa values correspond to the three ionizable hydrogens of phosphoric acid (H3PO4).

For phosphate buffers, the useful pH range is typically between 6.0 and 8.0, where the buffer capacity is highest.

But we often observed that when we dissolve 10 mM KH2PO4 in water, the pH is around 4.8, which is significantly lower than the pKa value of 7.20. This discrepancy can be explained by:

*Buffer capacity*: At 10 mM concentration, the buffer capacity of KH2PO4 is limited. The buffer capacity is the ability of a buffer to resist pH changes. At low concentrations, the buffer capacity is reduced.

*Acidic impurities*: KH2PO4 can contain acidic impurities, such as H3PO4 or H2PO4-, which can contribute to the lower pH.

*Dissociation equilibrium*: KH2PO4 dissociates into H2PO4- and K+ in water. The equilibrium constant (Ka) favors the acidic form (H2PO4-), leading to a lower pH.

8. Sodium dihydrogen phosphate and potassium dihydrogen phosphate which one is best choice for chromatography and why?

Sodium dihydrogen phosphate (NaH2PO4) and potassium dihydrogen phosphate (KH2PO4) are both commonly used in mobile phases for various chromatographic techniques

*pKa values:*

Both NaH2PO4 and KH2PO4 have the same pKa values, corresponding to the phosphate group:

pKa1 = 2.14

pKa2 = 7.20

pKa3 = 12.32

But their solubility plays a significant role in their selection 

Sodium dihydrogen phosphate (NaH2PO4) and potassium dihydrogen phosphate (KH2PO4) have different solubilities in water:

*Solubility at 25°C in water:*

1. Sodium dihydrogen phosphate (NaH2PO4):

    - 100 g/L (or 69.8% w/v)

    - Highly soluble

2. Potassium dihydrogen phosphate (KH2PO4):

    - 33 g/100 mL (or 22.6% w/v)

    - Moderately soluble

NaH2PO4 is approximately 3 times more soluble in water than KH2PO4.

But we also needs to consider solubility in organic solvents in gradient elution so if we need to mix with higher percentage of organic solvents KH2PO4 will be good choice as it is less soluble in water but contrary to that it's more soluble in organic solvent as compared to NaH2PO4.

But keep in mind that solubility can be affected by factors like pH, ionic strength, and presence of other solutions.

Conclusion: Buffers are indispensable in HPLC method development specially for controlling the ionization states of analytes. By selecting a buffer with a pKa close to the mobile phase pH, you can ensure consistent retention, better peak shapes, and improved chromatographic performance. 

Selecting the right HPLC column dimensions: A critical descision for optimal separation

 As an analytical scientist working on HPLC we often focus on selecting the right stationary phase which plays a crucial role in HPLC method development but in this article we will try to explore the importance of selecting the appropriate column dimensions.

Key parameters to consider include column length, pore size, particle size, internal diameter, and carbon loading. This article provides a detailed guide to selecting these parameters based on the nature of the analyte and the specific requirements of the analysis.

1) Particle size:

Particle size is the average particle size of the packing in the HPLC column.The standard particle size for HPLC columns was 5 µm for a long time, until the mid-1990s, when 3.5 µm became popular for method development. More recently, as higher speed and/or higher resolution is required, chromatographers have turned to packings with sub-2-3 µm, including 1.8 µm. 

The relationship between particle size and resolution is inversely proportional. Smaller particle sizes lead to higher resolution but also increase the column's back pressure. 

Now we know the smaller the particle size of the HPLC column higher the resolution but why is it so?

This is just because of the below scientific principles of chromatography.

A) Increased Surface Area

Greater Surface Area: Smaller particles have a larger surface area per unit volume compared to larger particles. This increased surface area allows for more interactions between the stationary phase and the analytes, enhancing the theoretical plate counts and resolution.

B) Reduced Eddy Diffusion

Eddy Diffusion: If you know about the Van Demeter equation you must know about Eddy diffusion. Eddy diffusion, a component of band broadening, is caused by the multiple flow paths that analyte molecules can take through the packed bed of particles. Smaller particles reduce the variation in these flow paths and reduce band broadening due to eddy diffusion and helps in improving resolution.

2) Column length:

Doubling the column length generally doubles the plate number and analysis time, enhancing resolution. However, longer columns also increase back pressure linearly.

If column length doubles, the plate number and analysis time also double. As column length increases, back pressure increases linearly. For example, a 2.1 x 100 mm column packed with 3.5 µm particles generates about 12,000-14,000 theoretical plates, an efficiency that can provide adequate separation for many samples. By reducing the particle size from 3.5 µm to 1.8 µm, the efficiency of the same 2.1 x 100 mm column is doubled to about 24,000 theoretical plates. However, this column generates a back pressure that is four times greater than the pressure of the same size column filled with 3.5 µm particles. Very often, an efficiency of 24,000 plates is not required, so the column length can be halved to 50 mm, with an expected efficiency of 12,000 plates. 

So the conclusion here is that the shorter column reduces analysis time and solvent consumption but lowers the resolution as compared to longer columns on the opposite side longer columns  provide higher resolution and theoretical plates as compared to shorter columns but with increased back pressure.

C) Internal diameter:

Internal diameter of column directly affect the solvent consumption and sensitivity. Reducing the column dimensions often results in high sensitivity and low solvent consumption. Narrower the internal diameter of column (2.1 to 3.0) mm often offer higher sensitivity faster analysis time but low sample loading capacity in the contrary wider internal diameter (4.6 to 10.0)mm provide higher sample loading capacity but may reduce sensitivity and resolution.

Even smaller columns are often less expensive to buy. In some cases, if the column diameter is reduced by half, sensitivity increases by four to five times (assuming the injection mass is kept constant). For example, when the same amount of the same sample is injected onto a 2.1 mm id column, the peaks are about three to five times higher than on an optimized LC than when the same amount of sample is injected onto a 4.6 mm id column.

3) Pore size:

Pore size is the average size of a pore in a porous packing. Its value is typically expressed in angstroms. The pore size determines whether a molecule can diffuse into and out of the packing. Therefore, the pore size of the packing material in your HPLC column plays an important role, since the molecules must 'fit' into the porous structure in order to interact with the stationary phase. Smaller pore size packings (pore size 80 to 120Å) are best for small molecules with molecular weights up to 2000. For larger molecules with MW over 2000, wider pore packings are required; for example, a popular pore size for proteins is 300Å. For polypeptides and many proteins, choose 200-450 Å, and choose 1,000Å and 4,000Å for very high molecular weight proteins and vaccines. 

4) Carbon loading:

Carbon Load refers to the % carbon content of the silica bonded stationary phase. Generally speaking, a high carbon load (example 18-25%) results in a more hydrophobic surface. The surface is also more resistant to high pH.

High carbon loading in the column means high hydrophobic  and increased retention of the non polar analytes therefore the columns with high carbon loading are good for the separation of nonpolar and mid polar compound while the column with low carbon loading retained polar components and good for separation of polar analytes.

Typical examples of such columns with carbon loading are as below 

- Zorbax C18 about 24%

- X bridge schied RP C18 about 17%

- X bridge Schied BEH about 18% 

Conclusion:

By understanding and optimizing these parameters—particle size, pore size, column length and carbon loading—analytical scientists can tailor their HPLC methods to achieve the desired balance between resolution, efficiency, and analysis time. Whether working with complex mixtures or routine analyses, the careful selection of column characteristics ensures robust, reproducible, and high-quality chromatographic separations.

Ultimately, the successful application of HPLC in various fields, from pharmaceuticals to environmental analysis, relies on making informed decisions about column selection based on a thorough understanding of these critical factors.

A Comprehensive Guide to Hydrophilic Interaction Liquid Chromatography (HILIC)

 

Hydrophilic Interaction Liquid Chromatography (HILIC) is a powerful and versatile chromatographic method in general used for the separation of polar compounds. It is especially powerful in applications where traditional reverse phase liquid chromatography (RPLC) fails to do separation and retention effectively, imparting particular advantages in terms of retention and selectivity for hydrophilic analytes. It is also known as Aqueous normal phase chromatography.

Hilic chromatography was first conceptualized and developed by Dr. Andrew Alpert. Dr. Alpert introduced the concept of HILIC in the mid-1990s, presenting it as a method particularly suited for the separation of polar compounds that are often difficult to retain using traditional Reversed-Phase Liquid Chromatography (RPLC).

Principle of Hilic chromatography 
HILIC operates on a mechanism that combines aspects of both normal-phase chromatography and reversed-phase chromatography. It uses a polar stationary phase and a relatively non-polar mobile phase, typically consisting of a high concentration of organic solvent (such as acetonitrile) with a small proportion of water or aqueous buffer. The fundamental principle of HILIC involves the partitioning of analytes between the polar stationary phase and the aqueous layer adsorbed on the stationary phase surface.

Mechanism

Stationary Phase: The stationary phase in HILIC is usually a polar material, such as silica, or a bonded phase with functional groups like diol, amino, or zwitterionic groups.

Mobile Phase: The mobile phase often comprises a high percentage of organic solvent (e.g., 70-90% acetonitrile) mixed with water or an aqueous buffer.

Retention Mechanism: Analytes are retained based on their polarity. Polar compounds have stronger interactions with the stationary phase and are retained longer, while less polar compounds elute more quickly.

Present HILIC theory dictates that HILIC retention is caused by a partitioning of the injected analyte solute molecules between the mobile phase eluent and a water-enriched layer in the hydrophilic HILIC stationary phase. The more hydrophilic the analyte is, the more is the partitioning equilibrium shifted towards the immobilized water layer in the stationary phase, resulting in more retention of the analyte. Retaintion in Hilic chromatography also cause by hydrogen bonding and Diple-Dipole interaction.

Advantages of HILIC

Enhanced Retention of Polar Compounds: HILIC is particularly effective for compounds that are too polar to be retained on reversed-phase columns, such as small organic acids, bases, and peptides.

Compatibility with Mass Spectrometry (MS): The high organic solvent content in HILIC mobile phases improves ionization efficiency in electrospray ionization (ESI), making HILIC ideal for coupling with MS for sensitive detection.

Improved Peak Shape and Resolution: HILIC can provide better peak shapes and resolution for polar compounds compared to reversed-phase chromatography, reducing issues such as tailing and co-elution.

Flexibility in Method Development: The ability to adjust the water content and buffer strength in the mobile phase allows fine-tuning of retention times and selectivity.

Method Development in HILIC

Developing a robust HILIC method involves several key considerations:
Selection of Stationary Phase: Choosing the appropriate stationary phase is crucial. Silica-based columns are common, but bonded phases with specific functional groups can enhance selectivity for particular analytes.

Optimization of Mobile Phase: The ratio of organic solvent to water, as well as the type and concentration of buffer, must be optimized to achieve the desired retention and resolution.

pH and Ionic Strength: Adjusting the pH and ionic strength of the aqueous component can significantly impact analyte retention and peak shape.

Column Temperature: Temperature can affect the viscosity of the mobile phase and the interaction between analytes and the stationary phase, thus influencing retention and separation efficiency.

Example of Some Hilic HPLC coloumn available:

1) ACQUITY UPLC BEH Amide Column (Waters Corporation):

Stationary Phase: Ethylene-bridged hybrid (BEH) particles with amide bonding.

Features: High pH stability, excellent retention of polar compounds, and compatibility with a wide range of mobile phases.ZORBAX HILIC Plus (Agilent Technologies):

2) ZORBAX HILIC Plus (Agilent Technologies):

Stationary Phase: Silica-based particles with proprietary bonding.

Features: Enhanced retention and selectivity for polar compounds, robust performance in both isocratic and gradient elution modes.Atlantis HILIC Silica Column (Waters Corporation):

3) Atlantis HILIC Silica Column (Waters Corporation)

Stationary Phase: Silica particles.

Features: Strong retention of highly polar compounds, ideal for metabolomics and small molecule analysis, good peak shape and resolution.

4) SeQuant ZIC-HILIC (Merck Millipore):

Stationary Phase: Zwitterionic bonding on silica particles.

Features: Unique zwitterionic stationary phase providing balanced retention of both anionic and cationic compounds, high resolution, and low bleed characteristics for MS detection.

5) Kinetex HILIC (Phenomenex):

Stationary Phase: Core-shell silica particles with diol bonding.

Features: High efficiency and fast separations, suitable for high-throughput analysis, improved peak capacity and sensitivity.

6) Nucleodur HILIC (Macherey-Nagel):

Stationary Phase: Silica particles with polar modification.

Features: Suitable for separation of a wide range of polar compounds, high chemical stability, and excellent batch-to-batch reproducibility.

Some real time API analysis based on Hilic mode:

​1.Vortioxetine

HILIC Method:
Column: ACQUITY UPLC BEH Amide
Mobile Phase: 85% Acetonitrile, 15% 20 mM Ammonium Formate (pH 3.0)
Flow Rate: 0.4 mL/min
Detection: MS detection

Reason: Vortioxetine is an antidepressant with polar characteristics. HILIC improves the retention and separation of vortioxetine and its metabolites, which might co-elute in RPLC, thus enhancing sensitivity and specificity, especially when coupled with mass spectrometry.

2. Adenosine

HILIC Method:
Column: Luna HILIC
Mobile Phase: 90% Acetonitrile, 10% 20 mM Ammonium Formate (pH 3.5)
Flow Rate: 0.6 mL/min
Detection: UV at 260 nm

Reason: Adenosine is a nucleoside with high polarity, making it difficult to retain and separate using RPLC. HILIC provides better retention and resolution, which is critical for accurate quantification and impurity profiling in pharmaceutical formulations.

3. Glycine

HILIC Method:
Column: SeQuant ZIC-HILIC
Mobile Phase: 75% Acetonitrile, 25% 10 mM Ammonium Formate (pH 4.0)
Flow Rate: 0.5 mL/min

Detection: UV at 210 nm or MS

Reason: Glycine is a simple amino acid with high polarity. HILIC is chosen for its ability to retain and separate glycine effectively, overcoming the limitations of RPLC where glycine elutes too early or not at all, thus ensuring better sensitivity and precision in analysis.

Commonly asked FAQs in Hilic chromatography:

1. What is HILIC chromatography?

Answer: Hydrophilic Interaction Liquid Chromatography (HILIC) is a chromatographic technique used to separate and analyze polar compounds. It employs a polar stationary phase and a predominantly organic mobile phase, typically consisting of a high percentage of acetonitrile with water or an aqueous buffer.

2. How does HILIC differ from Reversed-Phase Liquid Chromatography (RPLC)?

Answer: In RPLC, the stationary phase is non-polar, and the mobile phase is polar, primarily water with organic solvents like methanol or acetonitrile. In contrast, HILIC uses a polar stationary phase and a mobile phase with a high proportion of organic solvent (e.g., acetonitrile) mixed with water. This makes HILIC particularly suitable for retaining and separating highly polar compounds.

3. What types of stationary phases are used in HILIC?

Answer: Common stationary phases in HILIC include bare silica, and silica bonded with polar functional groups such as diol, amino, amide, or zwitterionic groups. Each type offers different selectivity and retention characteristics for various polar analytes.

4. What are the advantages of using HILIC?

Answer: The advantages of HILIC include enhanced retention and resolution of polar compounds, better peak shapes, compatibility with mass spectrometry, and flexibility in method development through adjustment of mobile phase composition and pH.

5. What kind of mobile phase is typically used in HILIC?

Answer: The mobile phase in HILIC usually consists of a high percentage (70-90%) of organic solvent like acetonitrile mixed with water or an aqueous buffer. The water content and buffer strength can be adjusted to optimize retention and separation.

6. Can HILIC be coupled with mass spectrometry (MS)?

Answer: Yes, HILIC is highly compatible with mass spectrometry. The high organic solvent content in HILIC mobile phases enhances ionization efficiency in electrospray ionization (ESI), leading to better sensitivity and lower detection limits.

7. Can I run 100% water as mobile phase in hillic chromatography.

Running 100% water as the mobile phase in Hydrophilic Interaction Liquid Chromatography (HILIC) is not recommended because it fundamentally contradicts the principles of HILIC. Here’s why?
1) Poor Retaintion:The high organic solvent content in HILIC mobile phases (usually 70-90% acetonitrile) is essential for retaining polar compounds. Using 100% water would lead to poor retention of polar analytes, causing them to elute very quickly or not be retained at all.
2) Stationary Phase Dehydration:
HILIC columns are designed to function with a substantial amount of organic solvent. Running 100% water can disrupt the equilibrium and interaction between the stationary phase and the mobile phase, potentially damaging the stationary phase over time or reducing its efficiency.

Selection of HPLC Column dimensions and it's importants

As we all know the heart of any HPLC system is the chromatographic column, where the separation of analytes occurs based on their interactions with the stationary phase within the column. The dimensions of the HPLC column play a crucial role in method development, influencing the efficiency, resolution, sensitivity, and robustness of the analytical method. In this article, we delve into the significance of selecting appropriate column dimensions and its impact on method development.

Column Length:
Doubling the column length generally doubles the plate number (Coloumn efficiency=N) and enhancing resolution. However, longer columns also increase back pressure and analysis time.  The length of the column determines the residence time of analytes within the stationary phase. Longer columns provide increased resolving power but may result in longer analysis times. Shorter columns offer faster analysis times but may sacrifice resolution. Thus, the column length should be chosen based on the desired balance between resolution and analysis time. You can simply understand by using below equation of column efficiency.

N = L/dp

Where N is the number of theoretical plates (Efficiency), is inversely proportional to particle size (dp) and directly proportional to column length (L).

Column Diameter:
Column diameter affects column efficiency, pressure, and sample loading capacity. Smaller diameter columns provide higher efficiency and better resolution due to reduced mass transfer effects. However, smaller diameter columns can also lead to increased back pressure, limiting the flow rate and sample loading capacity. Larger diameter columns offer higher sample loading capacity but may sacrifice resolution.
The choice of column diameter depends on the sample complexity, desired sensitivity, and available instrument capabilities.The inner diameter of a column affects solvent consumption and analytical sensitivity. Smaller diameter columns reduce solvent usage and increase sensitivity.

 
For example, injecting the same sample amount onto a 2.1 mm ID column produces peaks approximately four times higher than on a 4.6 mm ID column, significantly enhancing sensitivity.

Particle Size:
This refers to the average size of the packing particles within the column. Over the years, there has been a shift from standard sizes of 5 microns to smaller sizes like 3.5 microns, offering higher speed, Higher efficiency and higher resolution. The relationship between particle size and resolution is inversely proportional. Particle size of the stationary phase greatly influences column efficiency and resolution. Smaller particles provide higher surface area and better resolution but require higher backpressure to achieve optimal performance. On the other side larger particles offer lower backpressure but may result in reduced efficiency and resolution. The choice of particle size depends on the analyte properties, desired separation efficiency, and instrument specifications.

Pore Size:
Pore size of the stationary phase affects the retention and selectivity of analytes. Larger pore sizes are suitable for the separation of large molecules, while smaller pore sizes are ideal for small molecules.
The choice of pore size depends on the size and nature of the analytes to be separated.
Pore size refers to the average diameter of the pores on the silica material's surface. This dimension is critical because it determines the interaction between your analyte and the stationary phase. The pore size determines whether a molecule can diffuse into and out of the packing. The molecules must 'fit' into the porous structure in order to interact with the stationary phase. For small molecules (up to 2000 daltons), a pore size of 80-120 angstroms is suitable. For larger molecules like polypeptides and proteins, wider pores (200-450 angstroms) are needed. In cases of very large molecules, even larger pore sizes (1000-4000 angstroms) may be necessary. The larger pore size helps avoid peak shape asymmetry due to excessive analyte mass.

Column Material:
The choice of column material, such as silica-based or polymer-based, depends on the analyte properties, compatibility with mobile phase, and method requirements.
Silica-based columns are commonly used for their excellent chemical stability and broad applicability, while polymer-based columns offer alternative selectivity and compatibility with aqueous mobile phases.

Conclusion
In conclusion, the selection of HPLC column dimensions is a crucial aspect of method development, directly impacting the efficiency, resolution, and robustness of the analytical method. By carefully considering the column length, diameter, particle size, pore size, and material, analysts can tailor HPLC methods to meet specific analytical requirements and achieve accurate and reliable results.
selecting the right HPLC column dimensions depends on your specific analytical needs. For high throughput analysis, a short column with small particles is ideal. For complex separations, a longer column with small particle sizes might be necessary. In mass spectrometry, small internal diameter columns are preferable, while preparative chromatography often uses larger particles in larger diameter columns.